After the agent did not have a significant effect on the primary end point in a previous phase 3 trial, researchers used a secondary end point from that trial as the primary end point of a new phase 3...
Researchers sought to evaluate the prevalence of neuropathic pain features in patients with psoriatic arthritis (PsA), as well as the factors associated with neuropathic pain features.
Researchers evaluated the effect of upadacitinib on patient-reported outcomes in patients with rheumatoid arthritis who had an inadequate response to conventional synthetic DMARDs.
Authors of a study presented at the 2019 ACR/ARP Annual Meeting sought to better understand the effects of denosumab discontinuation in patients with rheumatoid arthritis who received treatment with...
In a cross-sectional study, researchers identified associations of ultrasonography changes in entheses with clinical characteristics in patients with PsA and compared the changes with healthy participants.
...
Sharon Chung, MD, lead investigator on the new practice guideline for vasculitis, discussed how the guideline will help rheumatologists manage classic systemic vasculitis conditions they may encounter in...
Authors of a new study presented at the 2019 ACR/ARP Annual Meeting evaluated the safety and efficacy of immune checkpoint inhibitor therapy in patients with preexisting autoimmune diseases.
The authors evaluated whether polypharmacy is associated with treatment response and serious adverse events among more than 22,000 patients with rheumatoid arthritis.
Intra-articular corticosteroids are frequently injected to relieve joint pain in osteoarthritis. But with emerging conflicting reports about safety, the authors of a new review investigated whether the...
The authors evaluated data of more than 2000 persons to compare demographic, clinical, and radiographic variables between patients with ankylosing spondylitis (AS), AS with psoriasis, axial psoriatic...
